Drew Taylor, MD
Dermatology · Denver, CONPI 1003173154
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $116,300 of the $135,340 with a category attached, or 85.9%. AbbVie accounts for 99.6% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $127,778, more than ten times the $1,158 reported in 2019. Among dermatology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $908.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$135K
- Misonix Inc$165
- Regeneron Healthcare Solutions, Inc.$110
- E.r. Squibb & Sons, L.L.C.$53
- Solta Medical, A Division Of Bausch Health US, LLC$47
- Musculoskeletal Transplant Foundation Inc.$41
- plus $158 from 7 others
What the payments were for
- Consulting fees$2,9502%
- Speaking & faculty fees$116,30086%
- Travel & lodging$12,1059%
- Food & beverage$3,9853%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 129 | $134,767 |
| Misonix Inc | 3 | $165 |
| Regeneron Healthcare Solutions, Inc. | 3 | $110 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $47 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $41 |
| Galderma Laboratories, L.p. | 2 | $41 |
| Novartis | 1 | $29 |
| Aclaris Therapeutics, Inc. | 1 | $22 |
| Biofrontera Inc. | 1 | $19 |
| Sanofi | 1 | $17 |
| Incyte Corporation | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$93,254
How this compares
$135,340 in reported general payments places this provider in the 95th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 306 | $3,132 |
| ValacyclovirValacyclovir Hcl | 39 | $671 |
| Clobetasol Propionate | 15 | $574 |
| Minoxidil | 27 | $560 |
| Triamcinolone Acetonide | 13 | $198 |
| Cefadroxil | 22 | $147 |
| Mupirocin | 18 | $125 |
| Hydrocortisone | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Denver
- Adrienne StewartDenver$102K
- Elizabeth ShurnasDenver$13K
- Carl DemidovichDenver$13K
- Elizabeth RobinsonDenver$11K
- Caroline HaganDenver$8K
- Lindsey BroussardDenver$7K
- Catherine CarreteroDenver$7K
- Channing HoodDenver$7K
- Marcjonathan SerotaLittleton$3.2M
- Ammon LarsenLoveland$620K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.